Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
07/12/2005 | CA2349142C Compositions and methods for stimulating gastrointestinal motility |
07/12/2005 | CA2094494C A 4-quinolone antibiotic compound as gamma ray scintigraphy diagnostic imaging agent |
07/07/2005 | WO2005061519A1 Kinase inhibitors |
07/07/2005 | WO2005061513A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
07/07/2005 | WO2005061512A1 Spiro-condensed indoline derivates as pesticides |
07/07/2005 | WO2005061500A1 Spiropiperidine derivatives for controlling pests |
07/07/2005 | WO2005061498A1 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon |
07/07/2005 | WO2005061497A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
07/07/2005 | WO2005061496A1 Aminopyridine-derivatives as inductible no-synthase inhibitors |
07/07/2005 | WO2005061475A2 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
07/07/2005 | WO2005061466A1 Novel phenylalanine derivative |
07/07/2005 | WO2005061460A1 Compounds, compositions, and methods |
07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
07/07/2005 | WO2005060959A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
07/07/2005 | WO2005060571A2 Antiprotozoal imidazopyridine compounds |
07/07/2005 | WO2005047258A3 Methods and compositions for selectin inhibition |
07/07/2005 | WO2005042498A3 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
07/07/2005 | WO2005037783A3 Use of tricyclic compounds as glycine transport inhibitors |
07/07/2005 | WO2005037052A3 Binding assay with labelled bispidine variant |
07/07/2005 | WO2005034869A3 Compounds and compositions as protein kinase inhibitors |
07/07/2005 | WO2005023808A3 Process for the preparation of renzapride and intermediates thereof |
07/07/2005 | WO2004058704A3 Quinazolinones as potassium channel modulators |
07/07/2005 | US20050148769 Tricyclic compound having spiro union |
07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
07/07/2005 | US20050148623 HIV protease inhibiting compounds |
07/07/2005 | US20050148622 Process for preparing acid salts of gemifloxacin |
07/07/2005 | US20050148620 Administering N-(2-{2-[4-amino-2-(2-methoxyethyl)-1H-imidazo[4,5-c]quinolin-1-yl]ethoxy}ethyl)methanesulfonamide as immune response modifier for treating viral and neoplastic diseases |
07/07/2005 | US20050148619 Sulfonamido ether substituted imidazoquinolines |
07/07/2005 | US20050148618 Tricyclic n-acyl compounds |
07/07/2005 | US20050148617 Drugs for eating disorders and treating obesity or anxiety with G protein |
07/07/2005 | US20050148613 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
07/07/2005 | US20050148603 Compositions useful as inhibitors of protein kinases |
07/07/2005 | US20050148602 Inhibitors of alphaLbeta2 mediated cell adhesion |
07/07/2005 | US20050148593 Compounds, compositions, and methods |
07/07/2005 | US20050148592 Use of riboflavin and flavin derivatives as chitinase inhibitors |
07/07/2005 | US20050148591 Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof |
07/07/2005 | US20050148586 Quinoxalinones |
07/07/2005 | US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
07/07/2005 | US20050148581 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance |
07/07/2005 | US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury |
07/07/2005 | US20050148573 Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
07/07/2005 | DE10357510A1 Heteroarylsubstituierte Benzole Heteroaryl-substituted benzenes |
07/07/2005 | DE10356579A1 Aminderivate Amine derivatives |
07/07/2005 | CA2792483A1 Hiv protease inhibiting sulfonamides |
07/07/2005 | CA2550958A1 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
07/07/2005 | CA2550843A1 Novel phenylalanine derivatives |
07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
07/07/2005 | CA2549510A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
07/07/2005 | CA2549389A1 Hiv protease inhibiting sulfonamides |
07/07/2005 | CA2549183A1 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon |
07/07/2005 | CA2548494A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
07/07/2005 | CA2547814A1 Spiropiperidine derivatives for controlling pests |
07/07/2005 | CA2540230A1 Aminopyridine-derivatives as inductible no-synthase inhibitors |
07/06/2005 | EP1549652A1 Fused azole-pyrimidine derivatives |
07/06/2005 | EP1549650A1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines |
07/06/2005 | EP1549649A1 Process for preparing haloalkyl pyrimidines |
07/06/2005 | EP1549648A1 Bicyclic heteroaromatic compounds as kinase inhibitors |
07/06/2005 | EP1549647A1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines |
07/06/2005 | EP1549646A2 Piperidine derivatives |
07/06/2005 | EP1549637A1 1- (indol-3-yl)carbonyl piperazine derivatives |
07/06/2005 | EP1549635A1 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases |
07/06/2005 | EP1549634A1 Novel substituted indoles |
07/06/2005 | EP1549620A1 Indazolecarboxamide derivatives, preparation and use thereof as cdk1, cdk2 and cdk4 inhibitors |
07/06/2005 | EP1549614A2 Vasculostatic agents and methods of use thereof |
07/06/2005 | EP1549315A2 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
07/06/2005 | EP1549313A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
07/06/2005 | EP1549309A2 Somatostatin analogue compounds |
07/06/2005 | EP1487833B1 Process for preparing a pharmaceutically active compound (granisetron) |
07/06/2005 | EP1077979B1 Method for producing (s,s)-benzyl-2,8-diazabicyclo 4.3.0]nonane |
07/06/2005 | EP1044001B1 Integrin receptor antagonists |
07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
07/06/2005 | CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
07/06/2005 | CN1634894A Spiro[benzocyclo-4'-piperidine-2'-one] template compound and method for preparing same |
07/06/2005 | CN1209363C Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
07/05/2005 | US6914066 1,2-annelated quinoline derivatives |
07/05/2005 | US6914052 Dideoxynucleoside analog compounds containing a dideoxy ribofuranosyl moiety that exhibit selective anti-viral activity coupled with substantially low toxicity toward host cells; treatment of HIV |
07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
07/05/2005 | CA2072541C Heterocyclic compounds, their production and use |
06/30/2005 | WO2005058913A1 Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents |
06/30/2005 | WO2005058909A2 Method of preparing porphyrin derivatives, porphyrin derivatives, uses thereof and pharmaceutical compositions |
06/30/2005 | WO2005058897A1 Spiroindoline derivatives having insecticidal properties |
06/30/2005 | WO2005058896A2 Synthesis of a polymorph of 4-amino-5-chloro-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate |
06/30/2005 | WO2005058895A1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo [1, 2-a] pyridine-6-carboxamide mesylate salt. |
06/30/2005 | WO2005058894A1 Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
06/30/2005 | WO2005058893A1 Tricyclic benzimidazoles |
06/30/2005 | WO2005058892A1 Pyrazolo [3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
06/30/2005 | WO2005058891A1 Pyrrolopyridine-substituted benzol derivatives for treating cardiovascular diseases |
06/30/2005 | WO2005058890A2 Hydronopol derivatives as agonists on human orl1 receptors |
06/30/2005 | WO2005058888A2 Oxazolidinone-quinolone hybrid antibiotics |
06/30/2005 | WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof |
06/30/2005 | WO2005058877A1 Novel chelating agents and highly luminescent and stable chelates and their use |
06/30/2005 | WO2005058841A2 Hiv protease inhibiting compounds |
06/30/2005 | WO2005058837A1 Benzazepine derivatives as histamine h3 antagonists |
06/30/2005 | WO2005058327A1 Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists |
06/30/2005 | WO2005058317A1 Glycine transporter-1 inhibirors |
06/30/2005 | WO2005039589A3 Cftr channel modulators |
06/30/2005 | WO2005035533A8 Modulators of serotonin receptors |